← back to search

Elisa ten Hacken

Harvard University · US
Area of research
Genetics · Immunology
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders, and Acute Lymphoblastic Leukemia research.
h-index
25
citations
2,369
works
122
NIH funding
primary concept
Chronic lymphocytic leukemia
email

Recent publications

International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations
Blood 2025cited by 11position: middledoi
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia
Blood 2024cited by 7position: middledoi
<i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Blood Cancer Discovery 2022cited by 27position: firstdoi
Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models
Cancer Research 2022cited by 15position: middledoi
A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation
Cancer Cell 2021cited by 60position: middledoi
Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
Cancer Cell 2019cited by 358position: middledoi
A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion
Cancer Cell 2019cited by 96position: middledoi
MCL-1 and PKA/AMPK Axis Fuel Venetoclax Resistance in Lymphoid Cancers
Blood 2019cited by 5position: middledoi
Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition
Leukemia 2016cited by 75position: middledoi
Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers
Nature Medicine 2014cited by 310position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Catherine J. Wu · Dana-Farber/Harvard Cancer Center2 papers (2019–2022)Donna Neuberg · Massachusetts General Hospital2 papers (2019–2022)Antonino Neri · University of Milan1 papers (2014–2014)Livius Penter · German Cancer Research Center1 papers (2022–2022)Paul G. Richardson · Harvard University1 papers (2014–2014)Giovanni Blandino · National Cancer Institute1 papers (2014–2014)Katrina Vanura · Comprehensive Cancer Center Vienna1 papers (2016–2016) · 1 papers (2019–2019)Markus Müschen · Yale Cancer Center1 papers (2016–2016)Giovanni Tonon · Vita-Salute San Raffaele University1 papers (2014–2014)Ana Lako · Harvard University1 papers (2019–2019)Caleb A. Lareau · Gladstone Institutes1 papers (2022–2022) · 1 papers (2016–2016)Kenneth J. Livak · Broad Institute1 papers (2022–2022) · 1 papers (2016–2016)Felix Seyfried · University of Regensburg1 papers (2016–2016)Alexis A. Jourdain · University of Lausanne1 papers (2019–2019)Jan A. Burger · The University of Texas MD Anderson Cancer Center1 papers (2016–2016)Christian Hurtz · University of Freiburg1 papers (2016–2016)Ignaty Leshchiner · Boston University1 papers (2019–2019)